Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 1/20 | 0.47 |
| ▸ | SLC18A3 | Q16572 | 6/20 | 0.41 |
| ▸ | IDO1 | P14902 | 2/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29533177 | 1.00 | ANPEP (0.47) | ANPEPSLC18A3IDO1SIGMAR1 | |
| SCHEMBL1990446 | 0.82 | ANPEP (0.56) | ANPEPSLC18A3IDO1SIGMAR1 | |
| SCHEMBL29687690 | 0.82 | ANPEP (0.56) | ANPEPSLC18A3IDO1SIGMAR1 | |
| SCHEMBL20063792 | 0.82 | ANPEP (0.56) | ANPEPSLC18A3IDO1SIGMAR1 | |
| SCHEMBL1990443 | 0.82 | ANPEP (0.56) | ANPEPSLC18A3IDO1SIGMAR1 | |
| SCHEMBL11824987 | 0.82 | PLAU (0.48) | ANPEPIDO1 | |
| SCHEMBL20095994 | 0.82 | ANPEP (0.56) | ANPEPSLC18A3IDO1SIGMAR1 | |
| Naphthalene SCHEMBL8201172 | 0.75 | ANPEP (0.50) | ANPEPSLC18A3IDO1SIGMAR1 | |
| SCHEMBL21473257 | 0.74 | ANPEP (0.41) | ANPEP | |
| SCHEMBL18033732 | 0.74 | ANPEP (0.41) | ANPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11634508-B2 | Peptide conjugates of cytotoxins as therapeutics | Cybrexa 2, Inc. (US) | 2023-04-25 | — | — | US | disclosed |
| US-20210009719-A1 | PEPTIDE CONJUGATES OF CYTOTOXINS AS THERAPEUTICS | Cybrexa 2, Inc. | 2021-01-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11634508-B2 | Peptide conjugates of cytotoxins as therapeutics | TOP1, TOP2A, TOP2B | ANPEP 29/4885SLC18A3 2141/4885IDO1 2522/4885 |
| US-20210009719-A1 | PEPTIDE CONJUGATES OF CYTOTOXINS AS THERAPEUTICS | TOP1, TOP2A, TOP2B | ANPEP 29/4885SLC18A3 2141/4885IDO1 2522/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.